Skip to content
Disclosery

Sio Capital Management, LLC

Follow

13F filer, CIK 1482416, NEW YORK, NY

Sio Capital Management, LLC reported $604,294,540 across 59 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 50.15% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001214659-26-010311

Period
2026-06-30
Reported value
$604M
Holdings
59
Top 10 weight
50.15%
New
17
Sold out
34

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ALLOnew+13,323,431$27.7M
GMEDnew+301,816$23.8M
CORadded+72,694$20.6M
IDYAnew+480,383$17.9M
CInew+57,750$15.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ICLRreduced-218,172-$37.9M
DNTHreduced-310,791-$30.3M
CORTexited-674,759-$27.2M
LIVNexited-421,615-$26.8M
EMBCexited-1,847,850-$16.3M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001214659-26-010311, largest first. % of portfolio is the value over $583,529,158, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
AVRANTERIS TECHNOLOGIES GLOBALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 2,370,000 shares; 2025Q1: 2,369,960 shares; 2025Q2: 1,839,022 shares; 2025Q3: 1,772,601 shares; 2025Q4: 1,874,641 shares; 2026Q1: 5,382,965 shares; 2026Q2: 5,545,984 shares 5,545,984$54.6M9.36%+163,019Timeline
CORCENCORA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 15,900 shares; 2026Q1: 100,894 shares; 2026Q2: 173,588 shares 173,588$49.1M8.42%+72,694Timeline
MMSMAXIMUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 155,142 shares; 2024Q4: 381,423 shares; 2025Q1: 468,352 shares; 2025Q2: 548,086 shares; 2025Q3: 557,615 shares; 2025Q4: 500,304 shares; 2026Q1: 768,825 shares; 2026Q2: 715,267 shares 715,267$38.5M6.59%-53,558Timeline
ALLOALLOGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 13,323,431 shares 13,323,431$27.7M4.75%newTimeline
GMEDGLOBUS MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 207,000 shares; 2025Q2: 245,570 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 301,816 shares 301,816$23.8M4.09%newTimeline
GSKGSK PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 268,873 shares; 2025Q4: not reported; 2026Q1: 385,879 shares; 2026Q2: 436,700 shares 436,700$22.9M3.92%+50,821Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 400,870 shares; 2024Q4: 240,870 shares; 2025Q1: 416,617 shares; 2025Q2: 810,274 shares; 2025Q3: 514,947 shares; 2025Q4: 526,002 shares; 2026Q1: 605,439 shares; 2026Q2: 695,315 shares 695,315$22.2M3.81%+89,876Timeline
WAYWAYSTAR HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 613,725 shares; 2026Q1: 1,642,236 shares; 2026Q2: 925,834 shares 925,834$19M3.26%-716,402Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 123,000 shares; 2024Q4: 123,000 shares; 2025Q1: 123,000 shares; 2025Q2: 124,230 shares; 2025Q3: 124,230 shares; 2025Q4: 75,730 shares; 2026Q1: not reported; 2026Q2: 480,383 shares 480,383$17.9M3.07%newTimeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 118,126 shares; 2026Q1: 132,496 shares; 2026Q2: 177,118 shares 177,118$16.9M2.89%+44,622Timeline
CITHE CIGNA GROUPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 26,503 shares; 2024Q4: 98,003 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 172,203 shares; 2026Q1: not reported; 2026Q2: 57,750 shares 57,750$15.9M2.73%newTimeline
SNYSANOFI SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 387,000 shares; 2025Q1: not reported; 2025Q2: 187,500 shares; 2025Q3: 562,703 shares; 2025Q4: 971,686 shares; 2026Q1: 239,671 shares; 2026Q2: 364,200 shares 364,200$15.5M2.66%+124,529Timeline
ICLRICON PUB LTD COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 195,500 shares; 2025Q1: 203,311 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 127,202 shares; 2026Q1: 306,358 shares; 2026Q2: 88,186 shares 88,186$15.3M2.63%-218,172Timeline
VTRSVIATRIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 730,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 954,299 shares 954,299$15.2M2.6%newTimeline
CCRNCROSS CTRY HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,068,821 shares; 2026Q1: 1,098,393 shares; 2026Q2: 1,098,393 shares 1,098,393$14.5M2.49%0Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 185,265 shares; 2025Q4: 185,265 shares; 2026Q1: 366,809 shares; 2026Q2: 307,657 shares 307,657$12.8M2.2%-59,152Timeline
ABTABBOTT LABORATORIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 186,574 shares; 2026Q2: 128,656 shares 128,656$11.7M2%-57,918Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 786,526 shares; 2025Q4: 477,067 shares; 2026Q1: 193,843 shares; 2026Q2: 110,022 shares 110,022$11.5M1.97%-83,821Timeline
ZBHZIMMER BIOMET HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 127,511 shares; 2024Q4: 174,811 shares; 2025Q1: 187,685 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 385,642 shares; 2026Q1: 62,613 shares; 2026Q2: 131,445 shares 131,445$11.3M1.94%+68,832Timeline
REGNREGENERON PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 18,000 shares 18,000$11.2M1.92%newTimeline
BMYBRISTOL-MYERS SQUIBB COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 193,500 shares 193,500$11.1M1.91%newTimeline
MDTMEDTRONIC PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 142,500 shares 142,500$11.1M1.91%newTimeline
VIRVIR BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 1,054,651 shares; 2025Q1: 473,607 shares; 2025Q2: 478,343 shares; 2025Q3: 478,343 shares; 2025Q4: 478,343 shares; 2026Q1: 1,498,620 shares; 2026Q2: 1,075,274 shares 1,075,274$11M1.88%-423,346Timeline
SENSSENSEONICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 115,784 shares; 2026Q1: 115,784 shares; 2026Q2: 1,592,692 shares 1,592,692$9.05M1.55%+1,476,908Timeline
EYPTEYEPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 721,785 shares; 2026Q2: 623,130 shares 623,130$8.91M1.53%-98,655Timeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,300,000 shares 1,300,000$8.59M1.47%newTimeline
ANIPANI PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 160,051 shares; 2025Q1: 87,298 shares; 2025Q2: 112,923 shares; 2025Q3: 55,723 shares; 2025Q4: 87,272 shares; 2026Q1: 265,543 shares; 2026Q2: 97,305 shares 97,305$8.05M1.38%-168,238Timeline
TARAPROTARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 1,437,500 shares; 2025Q1: 1,514,300 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,715,394 shares; 2026Q1: 1,969,839 shares; 2026Q2: 1,921,872 shares 1,921,872$7.34M1.26%-47,967Timeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 965,000 shares; 2026Q2: 1,003,562 shares 1,003,562$6.94M1.19%+38,562Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 208,500 shares 208,500$6.52M1.12%newTimeline
AQSTAQUESTIVE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 391,629 shares; 2025Q2: 947,489 shares; 2025Q3: 1,498,095 shares; 2025Q4: 993,095 shares; 2026Q1: 1,922,887 shares; 2026Q2: 1,486,175 shares 1,486,175$6.18M1.06%-436,712Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 116,997 shares; 2025Q2: 236,070 shares; 2025Q3: 577,750 shares; 2025Q4: 474,503 shares; 2026Q1: 370,045 shares; 2026Q2: 59,254 shares 59,254$5.78M0.99%-310,791Timeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 294,340 shares; 2026Q2: 127,808 shares 127,808$5.62M0.96%-166,532Timeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 968,597 shares; 2026Q2: 539,493 shares 539,493$5.3M0.91%-429,104Timeline
ZBIOZENAS BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 331,730 shares; 2026Q2: 208,557 shares 208,557$5.29M0.91%-123,173Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 451,793 shares; 2025Q1: 507,562 shares; 2025Q2: 512,338 shares; 2025Q3: 190,764 shares; 2025Q4: 81,883 shares; 2026Q1: 86,083 shares; 2026Q2: 73,952 shares 73,952$5.19M0.89%-12,131Timeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,078,965 shares; 2026Q2: 1,078,965 shares 1,078,965$4.92M0.84%0Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 3,747 shares; 2025Q1: 719,654 shares; 2025Q2: 726,851 shares; 2025Q3: 726,851 shares; 2025Q4: 613,888 shares; 2026Q1: 613,888 shares; 2026Q2: 617,675 shares 617,675$3.8M0.65%+3,787Timeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,214,239 shares; 2024Q4: 3,572,167 shares; 2025Q1: 3,735,396 shares; 2025Q2: 3,735,396 shares; 2025Q3: 2,636,548 shares; 2025Q4: 2,636,548 shares; 2026Q1: 3,076,580 shares; 2026Q2: 2,634,137 shares 2,634,137$3.53M0.6%-442,443Timeline
AVAHAVEANNA HEALTHCARE HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 369,036 shares 369,036$3.16M0.54%newTimeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 1,000,000 shares; 2025Q1: 2,232,000 shares; 2025Q2: 2,232,000 shares; 2025Q3: 1,427,495 shares; 2025Q4: 1,427,495 shares; 2026Q1: 1,252,381 shares; 2026Q2: 1,005,334 shares 1,005,334$2.7M0.46%-247,047Timeline
IMNMIMMUNOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 165,110 shares; 2026Q2: 124,168 shares 124,168$2.63M0.45%-40,942Timeline
ANTXAN2 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 657,200 shares; 2026Q2: 529,933 shares 529,933$2.56M0.44%-127,267Timeline
SERSERINA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,000,000 shares; 2026Q2: 1,000,000 shares 1,000,000$1.94M0.33%0Timeline
ALGSALIGOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 180,720 shares; 2025Q2: 335,937 shares; 2025Q3: 335,937 shares; 2025Q4: 335,937 shares; 2026Q1: 327,237 shares; 2026Q2: 327,237 shares 327,237$1.89M0.32%0Timeline
IBIOIBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 740,000 shares; 2026Q1: 904,268 shares; 2026Q2: 904,268 shares 904,268$1.58M0.27%0Timeline
XLOXILIO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 152,464 shares; 2026Q2: 152,464 shares 152,464$1.46M0.25%0Timeline
AORTARTIVION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 121,178 shares; 2024Q4: 121,178 shares; 2025Q1: 121,178 shares; 2025Q2: 158,736 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 48,481 shares 48,481$1.09M0.19%newTimeline
BBOTBRIDGEBIO ONCOLOGY THERAPEUTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 130,628 shares; 2025Q4: 130,628 shares; 2026Q1: 130,628 shares; 2026Q2: 130,628 shares 130,628$995K0.17%0Timeline
TELATELA BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 630,000 shares; 2025Q1: 630,000 shares; 2025Q2: 636,300 shares; 2025Q3: 636,300 shares; 2025Q4: 636,300 shares; 2026Q1: 636,300 shares; 2026Q2: 636,300 shares 636,300$477K0.08%0Timeline
ADGMADAGIO MED HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,288,461 shares; 2026Q1: 1,288,461 shares; 2026Q2: 698,989 shares 698,989$455K0.08%-589,472Timeline
NMTCNEUROONE MED TECHNOLOGIES COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 82,767 shares 82,767$252K0.04%newTimeline
ENVBENVERIC BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 180,000 shares 180,000$248K0.04%newTimeline
MODDMODULAR MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 26,190 shares; 2026Q2: 26,190 shares 26,190$118K0.02%0Timeline
QTIQT IMAGING HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 15,236 shares 15,236$62K0.01%newTimeline
RCKTWROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 400,000 shares; 2024Q4: 400,000 shares; 2025Q1: 400,000 shares; 2025Q2: 400,000 shares; 2025Q3: 400,000 shares; 2025Q4: 400,000 shares; 2026Q1: 400,000 shares; 2026Q2: 400,000 shares 400,000$1.48K<0.01%0Timeline
HUMAWHUMACYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 49,998 shares; 2024Q4: 49,998 shares; 2025Q1: 49,998 shares; 2025Q2: 49,998 shares; 2025Q3: 49,998 shares; 2025Q4: 49,998 shares; 2026Q1: 49,998 shares; 2026Q2: 49,998 shares 49,998$477<0.01%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
SLSSELLAS LIFE SCIENCES GROUP I COM NEWput1,230,700$18.2Mnew
HIMSHIMS & HERS HEALTH INC COM CL Acall75,000$2.6Mnew

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CORTCORCEPT THERAPEUTICS INC674,759$27.2Mshares
LIVNLIVANOVA PLC421,615$26.8Mshares
EMBCEMBECTA CORP1,847,850$16.3Mshares
ABVXABIVAX SA135,800$15.1Mshares
HAEHAEMONETICS CORP MASS220,672$12.4Mshares
TFXTELEFLEX INCORPORATED94,800$11.3Mshares
BMRNBIOMARIN PHARMACEUTICAL INC194,226$11Mshares
GPCRSTRUCTURE THERAPEUTICS INC209,093$10.1Mshares
BHVNBIOHAVEN LTD1,163,926$9.85Mshares
MNPRMONOPAR THERAPEUTICS INC173,506$9.51Mshares
CRNXCRINETICS PHARMACEUTICALS IN249,887$9.08Mshares
EWTXEDGEWISE THERAPEUTICS INC268,986$8.47Mshares
CMPSCOMPASS PATHWAYS PLC1,506,525$8.33Mshares
QDELQUIDELORTHO CORP359,011$5.9Mshares
REPLREPLIMUNE GROUP INC720,036$5.51Mshares
OGNORGANON & CO865,908$5.19Mshares
IRONDISC MEDICINE INC65,203$4.17Mshares
IARTINTEGRA LIFESCIENCES HLDGS C383,140$3.61Mshares
CNCCENTENE CORP DEL100,000$3.27Mput
PRQRPROQR THRAPEUTICS N V1,954,715$3.17Mshares
SISHOULDER INNOVATIONS INC210,641$3.06Mshares
KYMRKYMERA THERAPEUTICS INC32,235$2.68Mshares
CNTXCONTEXT THERAPEUTICS INC917,922$2.4Mshares
HYPRHYPERFINE INC1,000,000$1.08Mshares
FHTXFOGHORN THERAPEUTICS INC122,889$587Kshares
TERNTERNS PHARMACEUTICALS INC10,100$532Kshares
ENTAENANTA PHARMACEUTICALS INC40,000$505Kshares
NMTCNEUROONE MED TECHNOLOGIES CO496,614$386Kshares
BOLDBOUNDLESS BIO INC163,679$180Kshares
NYXHNYXOAH S A50,839$148Kshares
ELTXELICIO THERAPEUTICS INC11,700$125Kput
ERASERASCA INC5,000$80.9Kshares
OSCROSCAR HEALTH INC3,000$34.4Kput
SLPSIMULATIONS PLUS INC200$2.36Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001214659-26-010311 base2026-08-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001214659-26-010311 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001214659-26-006200 Quarter ended 2026-03-312026-05-14acceptance time not in the bulk data set
13F-HR 0001214659-26-001854 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR 0001214659-25-016415 Quarter ended 2025-09-302025-11-13acceptance time not in the bulk data set
13F-HR 0001214659-25-011950 Quarter ended 2025-06-302025-08-13acceptance time not in the bulk data set
13F-HR 0001214659-25-007756 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0001214659-25-002716 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001214659-24-019074 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001214659-24-014597 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0001214659-24-009242 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0001214659-24-002438 Quarter ended 2023-12-312024-02-13acceptance time not in the bulk data set
13F-HR 0001214659-23-014980 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0001214659-23-011184 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001214659-23-006952 Quarter ended 2023-03-312023-05-12acceptance time not in the bulk data set
13F-HR 0001214659-23-002122 Quarter ended 2022-12-312023-02-13acceptance time not in the bulk data set
13F-HR 0001214659-22-013603 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001214659-22-010095 Quarter ended 2022-06-302022-08-15acceptance time not in the bulk data set
13F-HR 0001214659-22-006910 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR 0001214659-22-002510 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0001214659-21-011737 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0001214659-21-008651 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR 0001214659-21-005410 Quarter ended 2021-03-312021-05-14acceptance time not in the bulk data set
13F-HR 0001214659-21-001839 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set
13F-HR 0001214659-20-009535 Quarter ended 2020-09-302020-11-16acceptance time not in the bulk data set
13F-HR 0001214659-20-007110 Quarter ended 2020-06-302020-08-14acceptance time not in the bulk data set
13F-HR 0001214659-20-004674 Quarter ended 2020-03-312020-05-15acceptance time not in the bulk data set
13F-HR 0001214659-20-001473 Quarter ended 2019-12-312020-02-14acceptance time not in the bulk data set
13F-HR 0001214659-19-007195 Quarter ended 2019-09-302019-11-14acceptance time not in the bulk data set
13F-HR 0001214659-19-005264 Quarter ended 2019-06-302019-08-14acceptance time not in the bulk data set
13F-HR 0001214659-19-003585 Quarter ended 2019-03-312019-05-15acceptance time not in the bulk data set
13F-HR 0001214659-19-001188 Quarter ended 2018-12-312019-02-14acceptance time not in the bulk data set
13F-HR 0001214659-18-007149 Quarter ended 2018-09-302018-11-14acceptance time not in the bulk data set
13F-HR 0001214659-18-005505 Quarter ended 2018-06-302018-08-14acceptance time not in the bulk data set
13F-HR 0001214659-18-003771 Quarter ended 2018-03-312018-05-15acceptance time not in the bulk data set
13F-HR 0001214659-18-001260 Quarter ended 2017-12-312018-02-14acceptance time not in the bulk data set
13F-HR 0001214659-17-006698 Quarter ended 2017-09-302017-11-14acceptance time not in the bulk data set
13F-HR 0001214659-17-005075 Quarter ended 2017-06-302017-08-14acceptance time not in the bulk data set
13F-HR 0001214659-17-003383 Quarter ended 2017-03-312017-05-15acceptance time not in the bulk data set
13F-HR 0001214659-17-001124 Quarter ended 2016-12-312017-02-14acceptance time not in the bulk data set
13F-HR 0001214659-16-014679 Quarter ended 2016-09-302016-11-15acceptance time not in the bulk data set
13F-HR 0001214659-16-013259 Quarter ended 2016-06-302016-08-15acceptance time not in the bulk data set
13F-HR 0001214659-16-011622 Quarter ended 2016-03-312016-05-16acceptance time not in the bulk data set
13F-HR 0001214659-16-009594 Quarter ended 2015-12-312016-02-16acceptance time not in the bulk data set
13F-HR 0001214659-15-007746 Quarter ended 2015-09-302015-11-13acceptance time not in the bulk data set
13F-HR 0001214659-15-006081 Quarter ended 2015-06-302015-08-14acceptance time not in the bulk data set
13F-HR 0001214659-15-004036 Quarter ended 2015-03-312015-05-15acceptance time not in the bulk data set
13F-HR 0001214659-15-001432 Quarter ended 2014-12-312015-02-17acceptance time not in the bulk data set